As of 2026-03-20, the EV/EBITDA ratio of Twist Bioscience Corp (TWST) is -23.61. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Twist's latest enterprise value is 2,598.10 mil USD. Twist's TTM EBITDA according to its financial statements is -110.04 mil USD. Dividing these 2 quantities gives us the above Twist EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.1x - 13.0x | 10.4x |
| Forward P/E multiples | 7.9x - 12.7x | 9.4x |
| Fair Price | (13.84) - (20.34) | (15.35) |
| Upside | -130.9% - -145.4% | -134.3% |
| Date | EV/EBITDA |
| 2026-03-13 | -22.76 |
| 2026-03-12 | -22.62 |
| 2026-03-11 | -24.76 |
| 2026-03-10 | -23.94 |
| 2026-03-09 | -25.58 |
| 2026-03-06 | -24.80 |
| 2026-03-05 | -25.76 |
| 2026-03-04 | -25.43 |
| 2026-03-03 | -24.64 |
| 2026-03-02 | -24.22 |
| 2026-02-27 | -24.79 |
| 2026-02-26 | -25.79 |
| 2026-02-25 | -26.27 |
| 2026-02-24 | -25.69 |
| 2026-02-23 | -25.44 |
| 2026-02-20 | -25.72 |
| 2026-02-19 | -27.89 |
| 2026-02-18 | -29.25 |
| 2026-02-17 | -28.11 |
| 2026-02-13 | -26.01 |
| 2026-02-12 | -25.20 |
| 2026-02-11 | -26.31 |
| 2026-02-10 | -25.98 |
| 2026-02-09 | -25.10 |
| 2026-02-06 | -26.08 |
| 2026-02-05 | -24.89 |
| 2026-02-04 | -25.46 |
| 2026-02-03 | -24.46 |
| 2026-02-02 | -24.73 |
| 2026-01-30 | -21.53 |
| 2026-01-29 | -21.82 |
| 2026-01-28 | -22.06 |
| 2026-01-27 | -22.38 |
| 2026-01-26 | -22.31 |
| 2026-01-23 | -22.57 |
| 2026-01-22 | -23.80 |
| 2026-01-21 | -22.97 |
| 2026-01-20 | -21.85 |
| 2026-01-16 | -21.72 |
| 2026-01-15 | -21.64 |
| 2026-01-14 | -20.95 |
| 2026-01-13 | -21.06 |
| 2026-01-12 | -19.84 |
| 2026-01-09 | -18.33 |
| 2026-01-08 | -18.00 |
| 2026-01-07 | -19.01 |
| 2026-01-06 | -19.19 |
| 2026-01-05 | -17.78 |
| 2026-01-02 | -16.70 |
| 2025-12-31 | -16.32 |